Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013
Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Community-acquired pneumonia in pediatric patients: New diagnostic priorities Source: Annual Congress 2012 - Asthma management Year: 2012
Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Prevalence rate and risk factors for hospital readmissions for asthma in children and adolescents in a tropical setting Source: Eur Respir J 2002; 20: Suppl. 38, 535s Year: 2002
Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Identifying risk factors in health care-associated pneumonia (HCAP) patients: nursing home (NH) residency vs. other risk factors Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
New and unconventional applications of NIV (i.e. weaning, endstage diseases, immunocompromised patients, post-surgical respiratory distress): potential benefits and risks Source: Annual Congress 2005 - PG17 - The present and future of noninvasive ventilation: technical and practical aspects Year: 2005
WHO program for acute respiratory infections in children: alternative approach in countries with high prevalence of wheezing disease Source: Eur Respir J 2001; 18: Suppl. 33, 287s Year: 2001
New approach to the rehabilitation of children frequently suffered from respiratory diseases Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact Source: Eur Respir J, 52 (2) 1702637; 10.1183/13993003.02637-2017 Year: 2018
Association of dyspnoea, mortality and resource use in hospitalised patients Source: Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019 Year: 2021
Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Early detection of pneumonia as a risk factor for mortality in burned patients in Menoufiya University Hospital Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016